{"id":2965,"date":"2024-04-16T23:30:13","date_gmt":"2024-04-16T23:30:13","guid":{"rendered":"https:\/\/www.fziomed.com\/usa\/?p=2965"},"modified":"2024-04-16T23:30:13","modified_gmt":"2024-04-16T23:30:13","slug":"fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress","status":"publish","type":"post","link":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/","title":{"rendered":"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress"},"content":{"rendered":"<p><strong>SAN LUIS OBISPO, California, April 16, 2024 \u2014 FzioMed, Inc.<\/strong> (\u201cFzioMed\u201d or the \u201cCompany\u201d), a recognized global leader in adhesion prevention, today announced it will attend the Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) congress April 22-24 in Rome, Italy. The Company will showcase its innovative Oxiplex\u00ae adhesion barrier gel product portfolio designed to reduce the formation of post-surgical adhesions following hysteroscopic and laparoscopic surgery. The HARTUS meeting is a new concept based on teamwork for enhancing the perinatal results in the infertility patient.<\/p>\n<p>FzioMed will highlight the unique benefits of its Oxiplex portfolio for intrauterine hysteroscopy and laparoscopic peritoneal procedures. Based on a patented formulation and more than 20 years of use, these barrier products provide a temporary, mechanical separation of tissues during the normal healing process, reducing adhesion formation. Oxiplex\/IU\u00ae and Oxiplex\/AP\u00ae gels offer ease of use combined with proven safety and clinical efficacy.<\/p>\n<p>FzioMed is sponsoring a lecture on Tuesday, April 23 at 2:30pm\/(14:30) CEST titled \u2018How to Prevent Intrauterine Adhesions\u2019 which will be given by Brunella Zizolfi, MD, PhD, a specialist of Gynecology and Obstetrics at Federico II University Hospital of Naples, Italy. Dr. Zizolfi and Attilio Di Spiezio Sardo, MD, PhD, Chief\u00a0 of Hysteroscopy at Federico II University Hospital and who has published clinical trial results with Oxiplex\/IU, will both be available at FzioMed\u2019s exhibitor booth (Booth #2) periodically throughout the congress to speak about the benefits of utilizing Oxiplex adhesion barriers.<\/p>\n<p>\u201cEven with the best procedural technique, adhesions can form in the cervical canal and intrauterine cavity following a variety of common procedures \u2013 including dilation and curettage, to myomectomy, adhesiolysis, and other hysteroscopic procedures. Intrauterine (IU) adhesions can cause a variety of complications, from pain and menstrual cycle abnormalities to infertility or inability to carry pregnancy to term,\u201d stated Todd Fanning, Vice President of Sales and Marketing. \u201cFormulated specifically for intrauterine procedures, our Oxiplex\/IU Adhesion Barrier Gel works in concert with the natural healing process to reduce adhesion formation. This can lead to improved patient satisfaction, reducing complaints and risk of re-operations.\u201d<\/p>\n<p>Oxiplex\/IU and Oxiplex\/AP Adhesion Barrier Gels are provided sterile and ready to use each with respective prepackaged applicators. Oxiplex\/IU includes a smooth, rounded tip applicator that allows for ease of insertion and application while the clear gel formula maintains local visibility. The proprietary applicator provided with Oxiplex\/AP allows for laparoscopic use to apply a single, consistent layer of gel over ovarian and peritoneal surfaces. No special storage, refrigeration, mixing, or handling is required. Oxiplex gels do not swell or migrate after application and their unique viscosity is flowable yet remain where applied. The Oxiplex portfolio of adhesion barrier products has been available since 2002 and have been used in nearly 1 million procedures worldwide.<\/p>\n<p>\u201cOur patented dual-polymer formulation combines two synthetic biocompatible polymers proven safe and effective over more than two decades of worldwide use. Oxiplex gels are inert, bioabsorbable, and contain no pharmaceutical agents or materials of human, animal, or bacterial origin,\u201d commented Gere diZerega, MD, FzioMed\u2019s Medical Director. \u201cReducing post-procedural pain and adhesiogenic complications can lead to improved reproductive health and risk of re-operations.\u201d<\/p>\n<p><strong>About FzioMed, Inc.<\/strong><\/p>\n<p>Pioneering biomaterials since 1996, FzioMed is a privately held and vertically integrated medical device company focused exclusively on preserving surgical excellence in spine, orthopedic, peritoneal and gynecological procedures. FzioMed is a recognized global leader in the surgical biomaterials markets for adhesion prevention.<\/p>\n<p>The Company develops and manufactures absorbable dhesion barriers based on its patented dual-polymer technology. Our patented dual polymer technology is tailored to meet the needs of specific clinical applications and markets its products in more than 70 countries under various brand names. FzioMed\u00ae, Oxiplex\u00ae, Oxiplex\/IU\u00ae, Oxiplex\/AP\u00ae, Oxiplex\/SP\u00ae, Dynavisc\u00ae, and Interpose\u00ae are registered trademarks; Intercoat\u2122 and Medishield\u2122 are trademarks; and <em>Preserve Surgical Excellence<\/em><sup>SM<\/sup> and <em>Pioneering Biomaterials Since 1996<\/em><sup>SM<\/sup> are sales marks \u2013 all of FzioMed, Inc.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.fziomed.com\/usa\">www.fziomed.com\/usa<\/a> or contact Steve Burt \u2013 CFO at <a href=\"mailto:investorrelations@fziomed.com\">investorrelations@fziomed.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SAN LUIS OBISPO, California, April 16, 2024 \u2014 FzioMed, Inc. (\u201cFzioMed\u201d or the \u201cCompany\u201d), a recognized global leader in adhesion prevention, today announced it will attend the Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) congress April 22-24 in Rome, Italy. The Company will showcase its innovative Oxiplex\u00ae adhesion barrier gel product portfolio designed to reduce [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[44],"tags":[],"class_list":["post-2965","post","type-post","status-publish","format-standard","hentry","category-news-releases","pmpro-has-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress - Fziomed USA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress - Fziomed USA\" \/>\n<meta property=\"og:description\" content=\"SAN LUIS OBISPO, California, April 16, 2024 \u2014 FzioMed, Inc. (\u201cFzioMed\u201d or the \u201cCompany\u201d), a recognized global leader in adhesion prevention, today announced it will attend the Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) congress April 22-24 in Rome, Italy. The Company will showcase its innovative Oxiplex\u00ae adhesion barrier gel product portfolio designed to reduce [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Fziomed USA\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-16T23:30:13+00:00\" \/>\n<meta name=\"author\" content=\"raincastle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"raincastle\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/\"},\"author\":{\"name\":\"raincastle\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/d08a21ddbf0edf65250f5c26f5e2f05c\"},\"headline\":\"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress\",\"datePublished\":\"2024-04-16T23:30:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/\"},\"wordCount\":675,\"commentCount\":0,\"articleSection\":[\"News Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/\",\"name\":\"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress - Fziomed USA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#website\"},\"datePublished\":\"2024-04-16T23:30:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/d08a21ddbf0edf65250f5c26f5e2f05c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#website\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/\",\"name\":\"Fziomed USA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/d08a21ddbf0edf65250f5c26f5e2f05c\",\"name\":\"raincastle\",\"sameAs\":[\"https:\\\/\\\/www.fziomed.com\"],\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/author\\\/raincastle\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress - Fziomed USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/","og_locale":"en_US","og_type":"article","og_title":"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress - Fziomed USA","og_description":"SAN LUIS OBISPO, California, April 16, 2024 \u2014 FzioMed, Inc. (\u201cFzioMed\u201d or the \u201cCompany\u201d), a recognized global leader in adhesion prevention, today announced it will attend the Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) congress April 22-24 in Rome, Italy. The Company will showcase its innovative Oxiplex\u00ae adhesion barrier gel product portfolio designed to reduce [&hellip;]","og_url":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/","og_site_name":"Fziomed USA","article_published_time":"2024-04-16T23:30:13+00:00","author":"raincastle","twitter_card":"summary_large_image","twitter_misc":{"Written by":"raincastle","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/#article","isPartOf":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/"},"author":{"name":"raincastle","@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/d08a21ddbf0edf65250f5c26f5e2f05c"},"headline":"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress","datePublished":"2024-04-16T23:30:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/"},"wordCount":675,"commentCount":0,"articleSection":["News Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/","url":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/","name":"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress - Fziomed USA","isPartOf":{"@id":"https:\/\/www.fziomed.com\/usa\/#website"},"datePublished":"2024-04-16T23:30:13+00:00","author":{"@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/d08a21ddbf0edf65250f5c26f5e2f05c"},"breadcrumb":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-inc-to-showcase-its-womens-health-adhesion-barrier-products-at-hysteroscopy-assisted-reproductive-technology-and-ultrasound-hartus-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fziomed.com\/usa\/home\/"},{"@type":"ListItem","position":2,"name":"FzioMed, Inc. to Showcase its Women\u2019s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.fziomed.com\/usa\/#website","url":"https:\/\/www.fziomed.com\/usa\/","name":"Fziomed USA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fziomed.com\/usa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/d08a21ddbf0edf65250f5c26f5e2f05c","name":"raincastle","sameAs":["https:\/\/www.fziomed.com"],"url":"https:\/\/www.fziomed.com\/usa\/author\/raincastle\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts\/2965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/comments?post=2965"}],"version-history":[{"count":0,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts\/2965\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/media?parent=2965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/categories?post=2965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/tags?post=2965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}